ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: PP10

Patients with Relapsing Polychondritis (“RP”) and an Advocate Manufactured Custom Cloth Masks to Combat COVID-19: This Mask Project Provided a Sense of Purpose, Created Unity, Increased Awareness of RP, Facilitated Research, and Generated Hope

Isabel Bautista1 and Michael Linn2, 1Relapsing Polychondritis Foundation, Wilmington, CA, 2Relapsing Polychondritis Foundation, New York, NY

Meeting: ACR Convergence 2020

Keywords: autoimmune diseases, cartilage, Cartilage Degradation, Inflammation

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2020

Title: Patient Perspectives (PP09–PP12)

Session Type: Patient Perspectives

Session Time: 12:00PM-1:00PM

Background/Purpose: In 2013, I was diagnosed with Relapsing Polychondritis (“RP”), a systemic inflammatory disease of unknown etiology that can be fatal. The disease affects multiple organs, particularly cartilaginous structures such as the ears, nose, airway, and joints as well as eyes, skin, vasculature, heart valves, and brain.

After my diagnosis, I joined a private online support group (the “RP Support Group”) to connect with other RP patients and gain a sense of empowerment and hope regarding this rare, debilitating disease.

Intervention:

In April 2020, a member of the RP Support Group posted an inquiry asking her peers if the group could have masks created to protect our community from COVID-19. Soon after, the inquirer and five other members volunteered to donate their time and materials to make cloth masks and ear savers for RP patients, and together, became known as the “RP Mask Team.”

The RP Mask Team received outstanding support from its community. Initially, we planned to work with the materials we had on hand. However, when the RP Foundation (polychondritis.org) and Race for RP (RaceForRP.org) donated custom fabric, the scope of the project grew and became an international disease awareness campaign.  With funding from individual donors, the RP Mask Team was able to provide high-quality, handmade cloth masks “free of charge” to each RP patient who requested one, regardless of their geographical location.

Maintenance:

With individual and institutional support, the RP Mask Team produced and shipped well over 300 masks and ear savers to patients throughout the United States, Canada, United Kingdom, France, Austria, Romania, Germany, Netherlands, Australia, and New Zealand.

Our “one of a kind” masks positively impacted international RP communities by combating the spread of COVID-19, while uniting patients, raising morale, increasing awareness of RP, and demonstrating success through collaboration.

The mask project also facilitated research. When posting information about the project, the RP Mask Team encouraged participation in the National Institutes of Health Patient Reported Symptoms Survey and a COVID-19 Patient Research Project being conducted with support from the Vasculitis Foundation, Vasculitis Clinical Research Consortium, and the RP Foundation.

Quality of Life:

Having a rare disease is often extremely difficult and disheartening.  Prior to the RP mask project, I was extremely stressed and had a sense of hopelessness because of COVID-19.  I was especially concerned about how the pandemic would impact people with an autoimmune disease, like myself.

The RP mask project changed my perspective.  It gave me a sense of purpose, created unity among the international RP communities, increased awareness about my disease, gave me an opportunity to help advance research, and perhaps most importantly, created hope.  When I follow the #RPmaskteam, I see photos of other patients proudly wearing their custom RP masks increasing awareness, and this fills me with joy. When I wear my RP mask, I feel proud, strong, heard, and noticed. I believe that our custom masks give the RP community one voice that says, “we are strong, and we will triumph over relapsing polychondritis.”

Relapsing Polychondritis Mask Makers worked together to produce cloth masks to protect RP patients from COVID-19

Relapsing Polychondritis Ear Saver Makers worked together to protect RP patients from pain and combat COVID-19

Relapsing polychondritis patients often experience burning or throbbing ear pain, so the RP Mask Team manufactured ear savers to secure handmade cloth masks


Disclosure: I. Bautista, None; M. Linn, None.

To cite this abstract in AMA style:

Bautista I, Linn M. Patients with Relapsing Polychondritis (“RP”) and an Advocate Manufactured Custom Cloth Masks to Combat COVID-19: This Mask Project Provided a Sense of Purpose, Created Unity, Increased Awareness of RP, Facilitated Research, and Generated Hope [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/patients-with-relapsing-polychondritis-rp-and-an-advocate-manufactured-custom-cloth-masks-to-combat-covid-19-this-mask-project-provided-a-sense-of-purpose-created-unity-increased-awareness-of/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/patients-with-relapsing-polychondritis-rp-and-an-advocate-manufactured-custom-cloth-masks-to-combat-covid-19-this-mask-project-provided-a-sense-of-purpose-created-unity-increased-awareness-of/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology